Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
Our knowledge is available 365 days for you.
Count on our multidisciplinary teams to exchange knowledge, ideas, and experience to develop and improve your project. As a specialist integrated CDMO we are dedicated to helping you bring new and off-patent drugs to market faster.
Challenge us
Our scientists attend the leading events of the pharma industry throughout the year where they share their knowledge and present their innovative work.
Did you miss the articles on Pharmaceutical Technology, Drug Development & Delivery, On-Drug Delivery or Chemistry Today? You are still in time to read them. Access them here:
|
|
Moving Beyond Particle Size Control Contributors: João Henriques (Group Leader, R&D Drug Product Development) Mafalda Paiva (Group Leader, Analytical Development) |
Improving Bioavailability & Solubility: Each Molecule Is Unique - Emerging Platforms Address Extreme Compounds Contributor: João Henriques (Group Leader, R&D Drug Product Development) |
|
|
Semi-Automation in Inhaler Testing - Exploring the Potential & Practicalities Discussion with João Pereira (Team Leader, R&D Analytical Development) Raquel Borda d' Água (Associate Analytical Chemist, R&D Analytical Development; Copley) |
Where Continuous Flow can help in today’s Pharmaceutical Industry Panel Discussion with Rudi Oliveira (Scientist, R&D Process Engineering and Scale-up) |
Did you miss our presentations at DDF, RDD, DDL or AIChE?
You are still in time to join. Access them here:
|
|
|
|
|
|
|
|
|
|